儿童非感染性葡萄膜炎继发黄斑水肿的临床病程与视力结局
该回顾性病例系列纳入以色列和英国4家三级医疗中心2005—2015年诊治的25例(33眼)儿童非感染性葡萄膜炎合并黄斑水肿患者,平均年龄8.5±3.4岁,最常见诊断为中间型葡萄膜炎。中位随访48个月,黄斑水肿中位消退时间6个月,24个月时75.8%患眼完全消退;基线视力≥20/40者占24.2%,3个月时升至57.6%(P<.0001)并此后保持稳定。结论认为儿童葡萄膜炎性黄斑水肿虽病程慢性,但预后良好。
要点
- 儿童非感染性葡萄膜炎合并黄斑水肿以中间型葡萄膜炎最常见。
- 黄斑水肿中位消退时间6个月,24个月时75.8%患眼完全消退。
- 基线视力≥20/40者3个月时由24.2%升至57.6%并保持稳定。
核心结论
- 儿童葡萄膜炎性黄斑水肿虽呈慢性病程,但总体预后良好。
- 需要更大规模随机对照试验来明确不同治疗方案之间的差异。
研究设计与样本
- 回顾性病例系列,检索以色列和英国4家三级医疗中心葡萄膜炎门诊2005—2015年诊治的儿童葡萄膜炎性黄斑水肿患者。
- 共纳入25例儿童(33眼),平均年龄8.5±3.4岁,中位随访48个月。
主要发现
- 最常见诊断为中间型葡萄膜炎,共14例(7例特发性、7例睫状体扁平部炎)。
- 黄斑水肿诊断时28眼(84.8%)葡萄膜炎处于活动期。
- 黄斑水肿中位消退时间6个月,24个月时25眼(75.8%)完全消退。
- 基线视力≥20/40者8眼(24.2%),3个月时升至57.6%(P<.0001),此后保持稳定。
- 未发现结局与黄斑水肿结构特征或具体治疗策略之间存在相关性。
关键数值与推荐
- 黄斑水肿完全消退定义为24个月时25眼(75.8%)达到完全消退。
- 视力结局以基线、3、6、12、24个月时视力≥20/40的患眼比例评估。
临床怎么用
- 对儿童非感染性葡萄膜炎应监测黄斑水肿,即使病程慢性也应积极管理以期视力改善。
- 治疗可包括全身和/或局部糖皮质激素、免疫抑制及生物制剂治疗。
局限性
- 为回顾性病例系列,样本量较小(25例33眼)。
- 未发现结局与黄斑水肿结构特征或具体治疗策略相关,作者指出需更大规模随机对照试验明确治疗方案差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the clinical course and visual outcome of macular edema (ME) in pediatric patients with chronic noninfectious uveitis. DESIGN: Retrospective case series. METHODS: The databases of the uveitis clinics of 4 tertiary medical centers in Israel and the UK were searched for all children treated for uveitic ME in the years 2005-2015. Data were collected from the medical records as follows: demographics, diagnosis, visual acuity, clinical and imaging findings, and treatment given specifically for ME. Findings at baseline and at 3, 6, 12, and 24 months were evaluated. RESULTS: The cohort included 25 children (33 eyes) of mean age 8.5 ± 3.4 years. The most common diagnosis was intermediate uveitis, in 14 children (7 idiopathic, 7 pars planitis). Uveitis was active at ME diagnosis in 28 eyes (84.8%). Median duration of follow-up was 48 months. Median time to resolution of ME was 6 months, with complete resolution in 25 eyes (75.8%) by 24 months. Baseline visual acuity was ≥20/40 in 8 eyes (24.2%), increased to 57.6% at 3 months (P < .0001), and remained stable thereafter. Treatment regimens included corticosteroids (systemically and/or locally), immunosuppression, and biologic therapies. No correlation was found between outcome and either structural characteristics of ME or specific treatment strategy. CONCLUSIONS: The prognosis of pediatric uveitic ME is favorable despite its chronic course. Larger randomized controlled trials are needed to define differences among treatment regimens.
引用
- Eiger-Moscovich M, Tomkins-Netzer O, Amer R, et al. Visual and Clinical Outcome of Macular Edema Complicating Pediatric Noninfectious Uveitis. Am J Ophthalmol. 2019. PMID: 30772346. doi:10.1016/j.ajo.2019.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。